1. Home
  2. KVYO vs TECH Comparison

KVYO vs TECH Comparison

Compare KVYO & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KVYO
  • TECH
  • Stock Information
  • Founded
  • KVYO 2012
  • TECH 1976
  • Country
  • KVYO United States
  • TECH United States
  • Employees
  • KVYO N/A
  • TECH N/A
  • Industry
  • KVYO
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KVYO
  • TECH Health Care
  • Exchange
  • KVYO Nasdaq
  • TECH Nasdaq
  • Market Cap
  • KVYO 8.8B
  • TECH 8.0B
  • IPO Year
  • KVYO 2023
  • TECH 1989
  • Fundamental
  • Price
  • KVYO $25.65
  • TECH $48.10
  • Analyst Decision
  • KVYO Buy
  • TECH Buy
  • Analyst Count
  • KVYO 20
  • TECH 9
  • Target Price
  • KVYO $47.30
  • TECH $81.25
  • AVG Volume (30 Days)
  • KVYO 1.8M
  • TECH 2.2M
  • Earning Date
  • KVYO 05-06-2025
  • TECH 05-07-2025
  • Dividend Yield
  • KVYO N/A
  • TECH 0.63%
  • EPS Growth
  • KVYO N/A
  • TECH N/A
  • EPS
  • KVYO N/A
  • TECH 0.98
  • Revenue
  • KVYO $937,464,000.00
  • TECH $1,196,016,000.00
  • Revenue This Year
  • KVYO $26.40
  • TECH $8.19
  • Revenue Next Year
  • KVYO $21.94
  • TECH $8.85
  • P/E Ratio
  • KVYO N/A
  • TECH $49.09
  • Revenue Growth
  • KVYO 34.29
  • TECH 4.46
  • 52 Week Low
  • KVYO $21.26
  • TECH $46.44
  • 52 Week High
  • KVYO $49.55
  • TECH $85.57
  • Technical
  • Relative Strength Index (RSI)
  • KVYO 32.99
  • TECH 33.97
  • Support Level
  • KVYO $25.95
  • TECH $46.44
  • Resistance Level
  • KVYO $28.26
  • TECH $53.00
  • Average True Range (ATR)
  • KVYO 1.95
  • TECH 3.30
  • MACD
  • KVYO 0.05
  • TECH -0.27
  • Stochastic Oscillator
  • KVYO 20.93
  • TECH 13.00

About KVYO Klaviyo Inc. Series A

Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: